Allspring Global Investments
BLUE

Allspring Global Investments’s bluebird bio BLUE Stock Holding History

Allspring Global Investments’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-143
Closed -$1.49K – 1842
2024
Q3 		$1.49K Buy
+143
New +$2.38K ﹤0.01% 2293
2024
Q1 		– Sell
-118
Closed -$3.27K – 2310
2023
Q4 		$3.27K Sell
118
-999
-89% -$60.9K ﹤0.01% 2074
2023
Q3 		$67.9K Sell
1,117
-778
-41% -$54.6K ﹤0.01% 2152
2023
Q2 		$125K Buy
1,895
+1,627
+607% +$119K ﹤0.01% 1980
2023
Q1 		$17.1K Sell
268
-911
-77% -$104K ﹤0.01% 2531
2022
Q4 		$163K Sell
1,179
-26
-2% -$3.66K ﹤0.01% 1892
2022
Q3 		$152K Buy
+1,205
New +$136K ﹤0.01% 1910

Other funds holding BLUE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Allspring Global Investments's BLUE Position: Q4 2024 in Review

Allspring Global Investments sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 143 shares — an estimated $1.49K sold.

Allspring Global Investments first reported a position in BLUE in Q3 2022 and held it in 7 quarters. The position peaked at $163K in Q4 2022. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • Allspring Global Investments reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 143 bluebird bio shares in Q4 2024, an estimated $1.49K.
  • Allspring Global Investments first reported a position in bluebird bio in Q3 2022 and held it in 7 quarters.
  • Allspring Global Investments's bluebird bio position peaked at $163K in Q4 2022.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.